Search - tctmd.com

Displaying 121 - 140 of 3208

Sort: Relevancy | Date

Presentation TCT 2016

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori

October 31, 2016

Presentation TCT 2016

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR

Presenter: Andreas Baumbach, Kurt Huber, Elmir Omerovic

October 31, 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presentation TCT 2016

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad

October 31, 2016

Presentation TCT 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors

October 31, 2016

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis From 7 Randomized Trials

Presentation TCT 2016

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients

Presenter: Murat Sezer, Niels van Royen

October 31, 2016

Presentation TCT 2016

Spain Presents: Detection and Treatment of Flow-Limiting Lesions in ACS Patients

Presenter: Murat Sezer, Niels van Royen, Javier Escaned

October 31, 2016

Presentation TCT 2016

Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients

Presenter: Murat Sezer, Niels van Royen

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt

October 30, 2016

News Conference News TCT 2016

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

TCT Daily Staff

October 30, 2016

Presentation TCT 2016

Do All Patients With ACS Need 1 Year (Or Longer) DAPT After PCI?

Presenter: John A. Bittl, Daniel I. Simon, Tullio Palmerini

October 30, 2016

Presentation TCT 2016

Can Propensity and Instrumental Variable Methods Overcome the Limitations of Observational Databases: Lessons From TRANSLATE-ACS

Presenter: Eugene H. Blackstone, Robert W. Yeh, Tracy Y. Wang

October 30, 2016

Presentation TCT 2016

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients With ACS and PCI

Presenter: Frederick Feit, Sripal Bangalore

October 30, 2016

Presentation TCT 2016

Radial Access in ACS: Case Closed?

Presenter: Francesco Burzotta, Sunil V. Rao, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Case Presentations: When OCT Changes Your Strategy in ACS

Presenter: Akiko Maehara, Francesco Prati, Fernando Alfonso

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients with History of Malignancy

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

Advertisement

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR

TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

The Netherlands Presents: Detection and Treatment of High-risk Plaques in ACS Patients

Spain Presents: Detection and Treatment of Flow-Limiting Lesions in ACS Patients

Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

Do All Patients With ACS Need 1 Year (Or Longer) DAPT After PCI?

Can Propensity and Instrumental Variable Methods Overcome the Limitations of Observational Databases: Lessons From TRANSLATE-ACS

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients With ACS and PCI

Radial Access in ACS: Case Closed?

Case Presentations: When OCT Changes Your Strategy in ACS

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

TCT 143: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients with History of Malignancy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content